Ischemic stroke (infrared laser): Small randomized trial (NEST-1) showed improved functional outcomes when initiated within 24 hours; authors recommended larger confirmatory trial.
Safety similar between groups; mortality and SAE rates not significantly different.
Peripheral neuropathy / diabetic neuropathy (MIRE/Anodyne): Randomized double-blind trials (e.g., Lavery et al 2008) found no significant differences between active and sham treatment on sensation, nerve conduction, transcutaneous oxygen, pain, or quality of life.
CMS (2006) concluded infrared devices are not reasonable and necessary for peripheral sensory neuropathy, wounds and ulcers, and related conditions.
Hemorrhoids (infrared coagulation): RCTs and comparative studies show infrared coagulation is an effective non-surgical option for Grade I-II hemorrhoids; rubber band ligation may be more effective for higher-grade hemorrhoids but associated with more postoperative pain.
Choice guided by hemorrhoid grade; IRC typically requires about 2 sessions.
Onychomycosis (laser/light): FDA-cleared lasers can produce temporary cosmetic improvement; randomized and controlled data are limited and inconsistent with uncertain long-term mycological cure.
Protocols and durability of effect not established.
Pressure ulcers: Guideline panels concluded evidence is insufficient to support routine use of infrared therapy for pressure ulcers.
Not recommended for routine use at this time.
Seasonal Affective Disorder (prevention): Only one small RCT compared bright white light, IR light, and no treatment; both bright and IR light reduced incidence numerically but evidence quality rated very low and imprecise.
Patient preferences should guide preventive treatment decisions given limited evidence.
Tendinopathy (PBM): Systematic review of 17 trials (n=835) found PBM alone produced similar pain decreases to other interventions; PBM plus exercise showed greater pain reduction and improved function versus sham plus exercise, but evidence quality ranged from very low to moderate.
Heterogeneity in PBM parameters and study quality limits conclusions; more robust RCTs needed.
Traumatic brain injury / other CNS indications: Small case series and early studies report mixed signals (e.g., pulsed transcranial PBM showed promise in small TBI series) but clinical studies are small, heterogenous, and require larger controlled trials.
Potential risks and heterogeneity of devices/parameters warrant further study.